These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11548209)

  • 1. Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections.
    Wang QM
    Prog Drug Res; 2001; Spec No():229-53. PubMed ID: 11548209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections.
    Wang QM
    Prog Drug Res; 1999; 52():197-219. PubMed ID: 10396129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human rhinovirus 3C protease as a potential target for the development of antiviral agents.
    Wanga QM; Chen SH
    Curr Protein Pept Sci; 2007 Feb; 8(1):19-27. PubMed ID: 17305557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Picornaviral 3C protease inhibitors and the dual 3C protease/coronaviral 3C-like protease inhibitors.
    Wang HM; Liang PH
    Expert Opin Ther Pat; 2010 Jan; 20(1):59-71. PubMed ID: 20021285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discovery.
    Ramajayam R; Tan KP; Liang PH
    Biochem Soc Trans; 2011 Oct; 39(5):1371-5. PubMed ID: 21936817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of 3C cysteine proteinases from Picornaviridae.
    Lall MS; Jain RP; Vederas JC
    Curr Top Med Chem; 2004; 4(12):1239-53. PubMed ID: 15320724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a cell-based protease assay for testing inhibitors of picornavirus 3C proteases.
    van der Linden L; Ulferts R; Nabuurs SB; Kusov Y; Liu H; George S; Lacroix C; Goris N; Lefebvre D; Lanke KH; De Clercq K; Hilgenfeld R; Neyts J; van Kuppeveld FJ
    Antiviral Res; 2014 Mar; 103():17-24. PubMed ID: 24393668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current research on picornavirus 3C protease].
    Wang H; Xie GC; Duan ZJ
    Bing Du Xue Bao; 2014 Sep; 30(5):579-86. PubMed ID: 25562970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of the Picornaviral 3C Proteinase in the Viral Life Cycle and Host Cells.
    Sun D; Chen S; Cheng A; Wang M
    Viruses; 2016 Mar; 8(3):82. PubMed ID: 26999188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.
    Binford SL; Maldonado F; Brothers MA; Weady PT; Zalman LS; Meador JW; Matthews DA; Patick AK
    Antimicrob Agents Chemother; 2005 Feb; 49(2):619-26. PubMed ID: 15673742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses.
    Kim Y; Lovell S; Tiew KC; Mandadapu SR; Alliston KR; Battaile KP; Groutas WC; Chang KO
    J Virol; 2012 Nov; 86(21):11754-62. PubMed ID: 22915796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward development of generic inhibitors against the 3C proteases of picornaviruses.
    Banerjee K; Bhat R; Rao VUB; Nain A; Rallapalli KL; Gangopadhyay S; Singh RP; Banerjee M; Jayaram B
    FEBS J; 2019 Feb; 286(4):765-787. PubMed ID: 30461192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes.
    Matthews DA; Dragovich PS; Webber SE; Fuhrman SA; Patick AK; Zalman LS; Hendrickson TF; Love RA; Prins TJ; Marakovits JT; Zhou R; Tikhe J; Ford CE; Meador JW; Ferre RA; Brown EL; Binford SL; Brothers MA; DeLisle DM; Worland ST
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11000-7. PubMed ID: 10500114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of quinone analogues as potential inhibitors of picornavirus 3C protease in vitro.
    Jung E; Lee JY; Kim HJ; Ryu CK; Lee KI; Kim M; Lee CK; Go YY
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2533-2538. PubMed ID: 29866517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad-spectrum inhibitors against 3C-like proteases of feline coronaviruses and feline caliciviruses.
    Kim Y; Shivanna V; Narayanan S; Prior AM; Weerasekara S; Hua DH; Kankanamalage AC; Groutas WC; Chang KO
    J Virol; 2015 May; 89(9):4942-50. PubMed ID: 25694593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibitors of picornavirus replication.
    De Palma AM; Vliegen I; De Clercq E; Neyts J
    Med Res Rev; 2008 Nov; 28(6):823-84. PubMed ID: 18381747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-covalent inhibitors of rhinovirus 3C protease.
    Baxter A; Chambers M; Edfeldt F; Edman K; Freeman A; Johansson C; King S; Morley A; Petersen J; Rawlins P; Spadola L; Thong B; Van de Poël H; Williams N
    Bioorg Med Chem Lett; 2011 Jan; 21(2):777-80. PubMed ID: 21183345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication.
    Kong JS; Venkatraman S; Furness K; Nimkar S; Shepherd TA; Wang QM; Aubé J; Hanzlik RP
    J Med Chem; 1998 Jul; 41(14):2579-87. PubMed ID: 9651162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteases of human rhinovirus: role in infection.
    Jensen LM; Walker EJ; Jans DA; Ghildyal R
    Methods Mol Biol; 2015; 1221():129-41. PubMed ID: 25261311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and mechanistic aspects of 3C proteases from the Picornavirus family.
    Arad D; Kreisberg R; Shokhen M
    J Chem Inf Comput Sci; 1993; 33(3):345-9. PubMed ID: 8320292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.